NCT07381946

Brief Summary

Post-extubation dysphagia (PED) is characterized by a range of clinical manifestations, including absence of visible swallowing effort, coughing or choking following liquid intake, and post-swallowing dysarthria. These impairments may lead to severe complications such as aspiration pneumonia, electrolyte disturbances, and malnutrition. Currently, the majority of hospitals both domestically and internationally have not implemented routine screening for PED or standardized swallowing rehabilitation programs, and research on the recovery of swallowing function in PED remains limited. This study aims to investigate the therapeutic efficacy of bilateral high-frequency repetitive transcranial magnetic stimulation (rTMS) combined with conventional swallowing training in patients with PED, and to evaluate the influence of oral feeding on functional recovery and the incidence of pneumonia. The study design is a single-center, randomized, single-blind, parallel-controlled trial. Participants with PED will be randomly assigned to either a swallowing training group or a bilateral high-frequency repetitive transcranial magnetic stimulation plus swallowing training group.The primary outcome measure is the Functional Oral Intake Scale (FOIS) score,which assesses oral feeding ability.Secondary outcomes include the Wakada Drinking Water Test(WST),degree of swallowing difficulty(GUSS),the incidence rate of pneumonia and length of stay.These secondary outcomes will provide a comprehensive evaluation of swallowing ability and hospitalization effects. Random grouping was conducted within 4 hours after extubation, and the treatment began within 2 hours and lasted for 3 consecutive days.Each rTMS session will target key brain regions.Swallowing training includes facial function training, sensory stimulation training, and airway protection techniques.The observation group received bilateral high-frequency transcranial magnetic stimulation in addition to the swallowing training.The data will be collected before and after the treatment.The primary outcome, FOIS score, will be used to assess the overall improvement in oral feeding ability.WST and GUSS data will be collected to evaluate a comprehensive evaluation of swallowing ability.The incidence rate of pneumonia and length of stay will be used to assess change in side effects. Statistical analyses will be performed using SPSS 22.0. Data will be presented as mean ± standard deviation. Between-group differences will be compared using independent samples t-tests. The study timeline spans from September 2025 to December 2026, including participant recruitment, intervention implementation, data collection, and analysis, as well as manuscript drafting. This study aims to provide new insights into the treatment methods for PED and explore a new rehabilitation approach that can be used in the ICU, with the expectation of improving swallowing disorders and reducing complications.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Sep 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress55%
Sep 2025Dec 2026

Study Start

First participant enrolled

September 1, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 9, 2026

Completed
24 days until next milestone

First Posted

Study publicly available on registry

February 2, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

February 2, 2026

Status Verified

January 1, 2026

Enrollment Period

1 year

First QC Date

January 9, 2026

Last Update Submit

January 27, 2026

Conditions

Keywords

DysphagiaExtubation failurerepetitive transcranial magnetic stimulation

Outcome Measures

Primary Outcomes (1)

  • Functional Oral Intake Scale ,FOIS

    The oral feeding ability was conducted using the Functional Oral Intake Scale (FOIS), which is divided into 7 levels. The higher the level, the better the oral intake ability.

    Baseline (before treatment), 3 days after treatment

Secondary Outcomes (3)

  • Wakada Drinking Water Test,WST

    Baseline (before treatment), 3 days after treatment

  • degree of swallowing difficulty,GUSS

    Baseline (before treatment), 3 days after treatment

  • length of stay

    at discharge

Other Outcomes (1)

  • the incidence rate of pneumonia

    30 days after extubation

Study Arms (2)

a bilateral high-frequency repetitive transcranial magnetic stimulation plus swallowing training

EXPERIMENTAL
Behavioral: Swallowing trainingDevice: a bilateral high-frequency repetitive transcranial magnetic stimulation

Swallowing training plus No intervention

PLACEBO COMPARATOR
Behavioral: Swallowing trainingOther: No intervention

Interventions

No intervention methods

Swallowing training plus No intervention

Swallowing training includes facial function training, sensory stimulation training, and airway protection techniques.

Swallowing training plus No interventiona bilateral high-frequency repetitive transcranial magnetic stimulation plus swallowing training

The interventional targets were the key cortical brain regions identified in preliminary studies, with stimulation applied to the bilateral oral and tongue regions.Parameters included a figure-of-8 coil, 10 Hz frequency, 5-second stimulation duration,55-second inter-train intervals, 10 repetitions, totaling 500 pulses per session, with each session lasting 10 minutes. Swallowing Training commenced within 10 minutes post-rTMS, following the same duration and intensity as the Swallowing Training Group . The treatment was conducted three days.

a bilateral high-frequency repetitive transcranial magnetic stimulation plus swallowing training

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age greater than 18 years;
  • Tracheal intubation for more than 48 hours;
  • Clear consciousness at the time of assessment, able to understand and follow the simple instructions of the researchers;
  • Patients have dysphagia, and the Functional Oral Intake Scale (FOIS) assessment is at levels

You may not qualify if:

  • Previous history of dysphagia;
  • Undergoing tracheotomy;
  • History of epilepsy;
  • Having metal implants in the brain;
  • Implanted with a cardiac pacemaker;
  • Under absolute isolation (such as open or infectious pulmonary tuberculosis);

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongnan hospital of Wuhan University, Wuhan, Hubei 430070

Wuhan, Hubei, 430070, China

Location

MeSH Terms

Conditions

Deglutition Disorders

Condition Hierarchy (Ancestors)

Esophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Blinding After the intervention allocation, the participants and data analysts will be blinded. This is a single - blinded, randomized, parallel - controlled study focusing on rTMS. In the rTMS group, a 20 - minute magnetic stimulation will be applied to the target brain area.. Before the final code - breaking, data analysts won't know the group to which the data they are analyzing belongs.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate chief physician

Study Record Dates

First Submitted

January 9, 2026

First Posted

February 2, 2026

Study Start

September 1, 2025

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

February 2, 2026

Record last verified: 2026-01

Locations